ActivePure Is Proven Against a Wide Range of Pathogens

  • SARS-CoV-2

  • Staphylococcus Aureus

  • Aspergillus niger endospores (toxic black mold surrogate)

  • H1N1 Influenza (Swine Flu)

  • H5N8 Influenza (Bird Flu)

  • MRSA

  • Bacillus globigii (C. difficile & anthrax surrogate)

  • MS2 Bacteriophage – RNA Virus

  • Staphylococcus epidermidis (Gram +)

  • PhiX-174 – DNA Virus

  • Erwinia Herbicola (Gram -)

  • Listeria monocytogenes

  • Murine Norovirus

  • E. Coli

  • Candida auris (fungus)

  • Botrytis cinerea (fungus)

  • Sclerotinia sclerotiorum (fungus)

  • Legionella pneumophila (bacteria)

  • Clostridium difficile (endospore)

  • Salmonella enterica (bacteria)

  • Aspergillus versicolor (fungus)

Certified Space Technology,
Perfected by ActivePure

The basis of ActivePure is Certified Space Technology. Our improvements to the technology have increased efficacy without using Ozone (O3). For our advancements, we have been declared Certified Space Technology and we are one of only 75 technologies that have been inducted into the Space Technology Hall of Fame in the past 30 years.

Proactive Pathogen Defense has been instantly adopted by hospitals for use in operating and acute care rooms. From the beginning, we knew that our technologies could help save thousands of lives. And we are now making it available for every home, business, and public space in America.

Air & Surface Pro Unit Testing

The Aerus Pure & Clean and Vollara Air & Surface Pro have been scientifically proven to reduce airborne SARS-CoV-2 novel coronavirus in the air.

  • ActivePure Technology was tested on live SARS-CoV-2 virus, not proxy or surrogate strains

  • The proven reduction rate of over 99.9% of airborne SARS-COV-2 within 3 minutes

  • Tests completed in partnership with a Biosafety Level 4 and Biosafety Level 3 combination lab team

VASP